Oblivion's Throne Chapter 70: Pythia Project

4.5 years earlier, at the dawn of the Pythia Project's first phase, an alien artifact had just been discovered.

The conference chamber exuded an austere elegance, its obsidian table polished to a mirror sheen under the soft, ambient glow of holographic displays. At the center of the room, a projection of the artifact spun slowly, its crystalline facets casting faint rainbows against the dark walls.

Valeria Zey'ran-Reyes rose to speak, her posture poised and deliberate. "This artifact is a singular event in human history. For the first ti, we have the ability to engineer evolution—not just predict or react to it, but to actively shape it."

She let the weight of her words settle over the room before continuing, her gaze sweeping across the gathered experts. "Consider what that ans: diseases eradicated at their genetic root, cognitive and physical potential unlocked, a future where humanity isn't at the rcy of random mutations or environntal pressures."

Rasmus Zey'ran, his arms crossed and his expression sharp, leaned back in his chair. "Forgive if I find the hubris unsettling. Evolution isn't a puzzle you solve, Lady Valeria," he said, the honorific slipping out unintentionally.

"It's a complex interplay of dynamic variables, each influencing the other in unpredictable ways. What do you think happens when you introduce 'structure' into such an inherently fluid system?"

Before Valeria could respond, Marek Reyes adjusted his holographic pad, his enthusiasm breaking through the room's tension. "That's the brilliance of this artifact. It doesn't override chaos—it harmonizes it."

A holographic molecular model appeared in the air, projected above Marek's pad. A glowing DNA helix, enveloped in a faint oscillating field, rotated slowly. "The crystalline structure exhibits adaptive resonance sequencing. It emits a spectrum of bio-signals that interact directly with a geno's hydrogen bonds and epigenetic markers. Instead of rewriting at random, the artifact identifies inefficiencies and tunes them into alignnt. Think of it as a musician tuning an instrunt."

Rasmus squinted at the model, his skepticism evident. "And what happens when it tunes the wrong string? DNA isn't a standalone system. It's highly interconnected. A minor adjustnt to one locus can create cascading effects across the geno. Are you suggesting the artifact can anticipate every downstream interaction?"

Marek hesitated for a fraction of a second before replying. "We've observed the artifact's field extending its influence across chromatin interactions, not just isolated loci. Preliminary trials show no evidence of cascading errors—it reads the geno holistically."

"Preliminary trials are just that preliminary." Rasmus repeated, his tone dripping with skepticism. "Introduce epigenetic stressors, environntal variables, or even stochastic mutations, and that 'perfect harmony' will collapse. Your 'targeted refinent' might destabilize entire lineages down the line."

Valeria raised a hand to calm the escalating debate. "That's why we're advocating a phased approach. Phase one focuses solely on genomic corrections for well-mapped single-gene disorders. We begin with what we know—conditions like cystic fibrosis, where the mutations are understood, and the outcos are predictable."

"And phase two?" Rasmus asked, his tone sharp.

"Incrental cognitive enhancents," Marek interjected. "We'll target neural pathways influencing mory, learning, and adaptation—areas with robust scientific backing. CREB and BDNF chanisms, for example. Enhancents will be subtle, asured, and continuously monitored."

Rasmus tilted his head. "And what if the enhancents amplify undesirable traits—aggression, paranoia, anxiety? The brain is a delicate system. Even minor adjustnts can have disproportionate effects."

Valeria nodded, acknowledging the point. "That's why phase two won't proceed without the most rigorous simulations and oversight. If instability arises, we'll halt and re-evaluate."

Marek Reyes leaned forward, his tone calm but charged with quiet pride, as the room settled into a focused silence. "While the artifact provides the genesis strain's stabilization, it's a precision tool with a critical flaw: proximity. It can only work when the sample is within its imdiate field of resonance. Beyond that, its power wanes. "

Rasmus Zey'ran tilted his head, skepticism flickering across his features. "Are you suggesting you've found a way to extend its influence without diminishing its precision?"

Marek's lips twitched into a faint smile. "Not exactly. The artifact's resonance remains localized, but the Reyes family has developed a way to bring its effects to scale. By leveraging our AI infrastructure, we can map the stabilized geno of a single cell, analyze its mutations, and simulate its interactions across an entire organism—all in real ti."

Erasmus sat in stunned silence, his mind racing. As a biologist, he had spent decades working with systems considered cutting-edge—the pinnacle of human ingenuity.

Yet even the most advanced gene-editing platforms and computational models he had ever encountered could not accomplish half of what Marek promised. The systems Erasmus had worked with were groundbreaking in their ti, capable of precise gene splicing and limited epigenetic modulation, but they remained tools that required extensive human oversight.

He turned toward Marek, his voice tinged with urgency. "Do you even realize the amount of data being streamlined every second? That would cripple any system we've ever built. Even our most advanced infrastructures would buckle under the weight of such continuous processing. And scalability—have you considered that? Every second this system operates, the complexity grows exponentially. Even if it functions for a day or two without failure, the system would only expand, demanding more resources and processing power with each iteration."

Marek said, smiling faintly, his tone calm but confident. "The Reyes family has developed a proprietary compression algorithm—a quantum data compressor, to be precise. It doesn't just track, register, and flag every mutation; it condenses the data into a format so efficient that a single quantum core can process billions of genomic interactions in real ti."

Rasmus shot back, his skepticism undiminished. "A quantum compressor? Even if it works in theory, how do you ensure it doesn't lose critical data in the process? Genomic information isn't just numbers—it's a living, dynamic system. One missed variable, one error, and your entire model falls apart."

Marek answered, gesturing to the hologram, which now displays a cascading stream of data points. "Think of it as a language translator. It takes the raw complexity of genomic interactions and translates it into a streamlined format. Every mutation, every epigenetic marker, every environntal variable is preserved, but in a way that the system can process efficiently. We've run thousands of simulations, and the highest error rate we've encountered so far is less than 0.001%."

Ermias Reyes gestured toward the projection, his voice deliberate. "The artifact gives us the foundation: a perfectly stabilized genesis strain. But our family's infrastructure transforms that foundation into sothing actionable. Our AI doesn't just map DNA—it tracks every mutation, every epigenetic interaction, every potential variable. It's an iterative system that learns with every sample."

The hologram expanded, displaying a branching cascade of simulations. From the original stabilized geno, thousands of variations unfolded, each one ticulously analyzed and color-coded.

Marek continued, his tone sharpening as he addressed the room. "It identifies how the genesis strain will interact with not just the target geno but also the broader epigenetic and environntal factors influencing it. "

Rasmus's eyes narrowed. "But what happens when you push the system too far? How do you ensure your AI doesn't miss sothing critical?"

Marek gestured toward the hologram, where a simulation displayed a mutation propagating through a geno. The AI flagged the mutation, adjusted paraters, and recalibrated the strain in real ti. "The AI doesn't operate in isolation. It cross-references every mutation with our global genomic database, which contains billions of data points accumulated over generations. If a risk is detected, the system adapts before the mutation takes hold."